Forget the Old Playbook: The New Science of Cartilage Regeneration
Recorded On: 05/02/2026
-
Register
- Non-member - $40
- Student/Other - Free!
- Member - $20
- GAC - Free!
Cartilage degeneration is common, debilitating, and dramatically affects quality of life. What if you could change that trajectory without injections or surgery?
In this lecture, chiropractor and renowned educator Tom Bayne shares compelling and exciting new research on a patented, newly available dietary supplement. Explore the data on walk score improvement, joint comfort, and quality of life reports.
Learning Objectives:
- Critically analyze the bidirectional relationship between cartilage degeneration and systemic inflammatory pathways
- Develop targeted strategies that enhance cartilage regeneration with safe, targeted supplementation options
- Improve measurable patient-centered metrics, including pain reduction, functional capacity, and quality of life.
Tom Bayne, DC
Microbiome Labs
Dr. Tom Bayne has 30 years of experience in the field of Functional Medicine both as a physician and an entrepreneur. As a Chiropractic physician trained in functional medicine Dr. Bayne spent 24 years learning how to manage patients using his functional medicine training. Understanding the physician's pain points and lack of clinically proven solutions to common patient complaints pushed Dr. Bayne to focus on product formulation and doctor training in tandem with running his practice. In 1997 he was part of a team that built a Functional Medicine based distribution network for physicians in Europe. In 2013, he worked with an elite group of practitioners and researchers to develop MegaSporeBiotic® –the world’s first pharmaceutical-grade, 100% spore-based probiotic. This led to the formation of Microbiome Labs, where his duties included overseeing research studies and creating innovative products to improve digestive and immune health. As President and co-founder of Microbiome Labs, Dr. Bayne traveled the world educating healthcare practitioners on the science of the gut microbiome, its relation to chronic diseases, and innovative solutions to improve the health of patients. Presently, he is the co-founder of 3 human health companies that are changing the way doctors help patients.


